about
The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expectedY-chromosome evidence for differing ancient demographic histories in the AmericasHistorical genetics: spatiotemporal analysis of the formation of the Brazilian populationAssociation of the gene encoding neurogranin with schizophrenia in malesPolymorphisms in the CYP2E1 and GSTM1 genes as possible protection factors for leprosy patientsDistribution of CYP2D6 alleles and phenotypes in the Brazilian populationToward more transparent and reproducible omics studies through a common metadata checklist and data publicationsFunctional characterization of G-protein-coupled receptors: a bioinformatics approach.DRD4 rare variants in Attention-Deficit/Hyperactivity Disorder (ADHD): further evidence from a birth cohort study.A multiplex PCR for 11 X chromosome STR markers and population data from a Brazilian Amazon Region.Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.Association of genetic variants with self-assessed color categories in BraziliansSeveral different lactase persistence associated alleles and high diversity of the lactase gene in the admixed Brazilian population.Uniparental (mtDNA, Y-chromosome) polymorphisms in French Guiana and two related populations--implications for the region's colonization.Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics.Influence of genetic, biological and pharmacological factors on warfarin dose in a Southern Brazilian population of European ancestry.Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis.Genome-wide association study of warfarin maintenance dose in a Brazilian sampleHigh interpopulation homogeneity in Central Argentina as assessed by Ancestry Informative Markers (AIMs).Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical OriginGenetic variation within the Tupi linguistic group: new data on three Amazonian tribes.IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in BrazilFurther blood genetic studies on Amazonian diversity--data from four Indian groups.Gene-environment interaction in externalizing problems among adolescents: evidence from the Pelotas 1993 Birth Cohort Study.Impact of genetic polymorphisms on the efficacy of HMG-CoA reductase inhibitors.Haplotypes of the IL10 gene as potential protection factors in leprosy patients.A review of psychiatric genetics research in the Brazilian population.A current update on ADHD pharmacogenomics.Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.Pharmacogenetic approach for a better drug treatment in children.Genetics of attention-deficit/hyperactivity disorder: current findings and future directions.ADHD pharmacogenetics across the life cycle: New findings and perspectives.Parkinson's disease pharmacogenomics: new findings and perspectives.The dopamine transporter role in psychiatric phenotypes.PPARA gene and phenprocoumon: a new predictor of response variability.Application of the F(ST) statistics to explore pharmacogenomic diversity in the Brazilian population.Impact of population diversity on the prediction of 7-SNP NAT2 phenotypes using the tagSNP rs1495741 or paired SNPs.T-cell and chemokine receptor variation in south Amerindian populations.Molecular diversity at the CYP2D6 locus in healthy and schizophrenic southern Brazilians.
P50
Q21091060-61D96F5D-5AFF-4E9B-ACF6-AAAD57FF42BAQ24532808-DF2187B8-A488-4142-9864-AD689869B7DFQ28181536-9A49C30C-29D1-43A3-BDB1-645CA00F52ECQ28276741-1A72FC79-CEBF-4825-8892-2879CE8FDB3CQ28484397-BC09012A-42FA-4EE9-AF6E-2A554BB154E3Q28543940-B7C62D68-77D5-4851-AC93-E67DE772A8FAQ28660033-29E8974A-3D44-4399-B519-CA522E473E9AQ30009384-753BF600-9DD1-4E04-9CA1-51B150C7F7B6Q31147188-FF7D8485-0548-4D1C-A1FE-DD2152D26C35Q33393070-29EB02DB-2906-4409-9AC4-1E2019E680D6Q33977144-A41956D8-D5DB-423B-AF94-2FA79BDED581Q34397390-6E5AC083-0CE2-46AF-B447-97706977194FQ34431378-A0B24880-2CD3-4304-AE6D-93F0754DDFCFQ34668002-9BCD4638-2D64-412C-8048-C6860470E134Q35082743-F2A909A0-770F-46FD-950B-53480AEE206FQ35219654-D06DF0D8-C8BF-465C-962E-D8FC56D0B1ABQ35661622-746E2E16-661C-4B64-AC4A-98982604F33FQ36068687-E2B08D0D-FB20-453B-9B7D-4A132C53C56AQ36182042-9B95A0F7-84AC-402B-8B32-545AFA4AD4C9Q36192663-8127457E-0B1C-4153-8012-39BC5AC92386Q36374718-FB0B61CE-2DE3-45AA-8954-1ACA649A9591Q36443861-0D29A998-9D93-457F-B5C6-11C9D05313C6Q36510364-75F13C79-62F1-4D28-BECE-A862710C7D7EQ36729438-3349BECE-3AB9-44C7-8B88-BD882B34955DQ37076902-A9331AB9-D042-4E08-B618-DE187BC8B02FQ37183381-FE411EFB-538E-4AA1-8DA4-3685CAF3E15EQ37252377-D1FE9558-4424-4B0E-8981-8A3F6E8DCEEDQ37541750-23E9F083-4E77-4602-9907-EFE5CCA8241EQ37710514-D2616372-AC3F-43C4-8FDD-C3BD532E4B99Q37724221-5B3F29D8-A663-4073-815D-E9AF58DD45D9Q37761735-1688554F-2281-4F27-8AD5-2EB50687AE1DQ38094814-D87FF587-9B2B-4495-B7B9-8C372BF3C701Q38209972-BE31F920-9E4E-4BB1-8453-64A67C2CCAE4Q38241678-6B965B0C-97BD-4774-A868-57F4EE5EF77AQ38648135-160A6455-D3FC-4DAF-B3EE-A4EE207DD4DEQ39086568-D8C80911-A5F5-4FB6-B219-7196EAE92DEEQ39495836-0E5F9103-CF56-4AAD-B8E2-6020C65723F4Q39495843-D69265AB-6E16-4E68-BDEF-91F05504EB41Q39721513-EE2C92F4-8283-408E-B70F-F2CD8BCB4749Q39946483-B033CB9B-233C-4807-A3BB-BD8F2CB84827
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mara H Hutz
@nl
Mara H Hutz
@sl
Mara H. Hutz
@en
Mara H. Hutz
@es
Mara Hutz
@fr
type
label
Mara H Hutz
@nl
Mara H Hutz
@sl
Mara H. Hutz
@en
Mara H. Hutz
@es
Mara Hutz
@fr
altLabel
Mara H. Hutz
@en
prefLabel
Mara H Hutz
@nl
Mara H Hutz
@sl
Mara H. Hutz
@en
Mara H. Hutz
@es
Mara Hutz
@fr
P106
P1153
16199584000
P21
P31
P496
0000-0002-9146-1229